Back to Search Start Over

PS3-3 Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors.

Authors :
Doi, T.
Patel, M.R.
Koyama, T.
Falchook, G.S.
Friedman, C.
Piha-Paul, S.A.
Gutierrez, M.
Awad, M.
Mattour, A.
Satoh, T.
Takahashi, S.
Tsunoda, T.
Kadowaki, S.
Watanabe, Y.
Okamoto, N.
Goto, H.
Yoshizuka, N.
Qian, M.
Qian, X.
Johnson, M.
Source :
Annals of Oncology. Oct2024:Supplement 3, Vol. 35, pS1315-S1315. 1p.
Publication Year :
2024

Subjects

Subjects :
*BIOMARKERS
*TUMORS

Details

Language :
English
ISSN :
09237534
Volume :
35
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
180495788
Full Text :
https://doi.org/10.1016/j.annonc.2024.07.717
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details